Oxy-Powder®
14-Day Safety Study Acute Toxicity Report

PROJECT NO.12203
ACUTE ORAL TOXICITY OF OXY-POWDER®
IN SPRAGUE DAWLEY RATS

SUMMARY AND CONCLUSION

This study was designed to determine the acute oral toxicity profile of Oxy-Powder® in Sprague Dawley rats. The sighting study did not result in any signs of intoxication at the dose level of 2000 mg/kg body weight and the animal survived; therefore, one animal was treated with the higher dose of 5000 mg/kg body weight. No signs of intoxication were observed in animals treated at the dose level of 5000 mg/kg body weight. Therefore the main study was continued at the dose level of 5000 mg/kg body weight. The main study did not result in any signs of intoxication at the dose level of 5000 mg/kg body weight. All animals survived through the study period of 14 days. Gross pathological examination did not reveal any abnormalities. (more…)

[ Read More ]

Oxy-Powder®
IN-VITRO ANTI-BACTERIAL ACTIVITY TEST

The results very clearly indicate that Oxy-Powder® is ineffective in killing the test cultures in-vitro.

It is very encouraging to see that the Probiotic organisms Lactobacillus bulgaricus is also not killed by Oxy-Powder®. This indicates the survival of Probiotic organisms even when Oxy-Powder® is acting in the large intestine and colon region against constipation. Other normal physiological processes including generation of B complex factors by the Probiotic organisms shall continue in routine and would avoid administration of B complex factors externally to the patients suffering from constipation and undergoing treatment with Oxy-Powder®. (more…)

[ Read More ]

This summary report has been extracted from the Original Phase I, II, and III active, controlled Clinical Studies on Oxy-Powder®. We tested many components of Oxy-Powder® including acute toxicity, sub-chronic toxicity and anti-bacterial activity. We also tested the effectiveness of Oxy-Powder® for symptoms of chronic constipation, and IBS (Irritable Bowel Syndrome). For ease of reading, we summarized the results of each test.
(more…)

[ Read More ]

This summary report has been extracted from the Original Phase I, II, and III active, controlled Clinical Studies on Oxy-Powder®. We tested many components of Oxy-Powder® including acute toxicity, sub-chronic toxicity and anti-bacterial activity. We also tested the effectiveness of Oxy-Powder® for symptoms of chronic constipation, and IBS (Irritable Bowel Syndrome). For ease of reading, we summarized the results of each test.

According to the Rome II criteria for constipation, all patients in the study were suffering from constipation for 12 weeks (3 months) or more.
(more…)

[ Read More ]